Baker Brothers Advisors - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 91 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,872,685
-62.9%
3,140,473
-50.2%
0.03%
-63.0%
Q2 2023$15,824,810
+43.4%
6,304,7050.0%0.09%
+53.3%
Q1 2023$11,033,234
+29.8%
6,304,705
+215.2%
0.06%
+17.6%
Q4 2022$8,500,0002,000,0000.05%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Polar Capital Holdings Plc 5,800,000$27,260,0000.16%
Inscription Capital, LLC 17,000$80,0000.03%
ExodusPoint Capital Management, LP 185,844$873,0000.01%
HoyleCohen, LLC 10,359$49,0000.01%
Virtu Financial LLC 10,835$51,0000.01%
Tower Research Capital LLC (TRC) 3,783$18,0000.00%
Renaissance Technologies 253,212$1,190,0000.00%
Baillie Gifford 372,261$1,749,0000.00%
CAPSTONE INVESTMENT ADVISORS, LLC 37,238$175,0000.00%
BREWIN DOLPHIN LTD 1,970$9,2590.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders